Labcorp (NYSE:LH) reported second-quarter 2026 revenue growth, margin expansion and higher adjusted earnings, prompting the laboratory services company to raise the midpoint of its full-year revenue and adjusted EPS guidance.
Revenue rose 5.8% year over year to $3.7 billion, while adjusted operatin
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 5.8% year on year to $3.73 billi...
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 5.8% year on year to $3.73 billi...
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) will be announcing earnings results this Thursday before market hours. Here’s what to look for. Lab...
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as...
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to beco...
Labcorp currently trades at $265.08 per share and has shown little upside over the past six months, posting a middling return of 4.4%. Is now the time to buy...
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ...
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch...
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recentl...
Labcorp’s first quarter was marked by continued growth in both its Diagnostics and Biopharma Laboratory Services businesses, supported by strategic partnersh...
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 5.8% year on year to $3.54 bill...
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) announced better-than-expected revenue in Q1 CY2026, with sales up 5.8% year on year to $3.54 billi...
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) will be reporting results this Thursday before market open. Here’s what you need to know. Labcorp m...
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch...
